KCT0005945已完成未知
An 8-week, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of red Platycodon grandiflorum root extract on enhancement of immune function
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1. Adult men and women aged =20 and <75 years
- •2. Subjects who agreed to participate in this study and sign the informed consent
排除标准
- •1. Subjects with WBC <3,000 cells/µl or >10,000 cells/µl in the screening test
- •2. Subjects with BMI <18.5kg kg/m2 or >35 kg/m2 in the screening test
- •3. When it is not possible to perform the test conducted in the human study
- •4. Subjects who have the following symptoms/diseases or history
- •- Subjects who have a medical history of gastrointestinal diseases (Crohn's disease, etc.) or operation (except appendectomy or herniotomy)
- •- Uncontrolled diabetic patients (Fasting blood glucose = 180 mg/dL or in the case of medication changed or started anew within three months)
- •- Uncontrolled hypertension patients (blood pressure = 160/100 mmHg or in the case of medication changed or started anew within three months)
- •- Subjects with acute severe cardiovascular disease such as heart failure, myocardial infarction, and stroke
- •- Subjects who have immune system disease or severe liver failure, renal failure or history
- •- Subject who have thyroid gland or pituitary gland disease
- •- Subjects who have systemic diseases such as malignant tumors, lung diseases, leukemia, collagenosis, multiple sclerosis, allergic skin diseases and other autoimmune diseases or history
- •5. Subject who show the following results in the screening test
- •- AST, ALT > more than 2 times of the upper limit
- •- Abnormal kidney function:
- •Serum creatinine > 2.0 mg/dL
- •6. Subject who get a medical history of psychopharmacotherapy with in last 2 months before screening test
- •7. Subject who have experienced taking medicines, herbal medicines, and health functional foods that may affect their immune system within two weeks prior to the first intake of the experimental food (the health functional foods can be participated after a week's recess before the first intake of the clinical product)
- •8. When the use of prohibited drugs is expected during the study period
- •9. Subjects who have hypersensitivity history due to experimental product or ingredients
- •10. Subject who were participated in other clinical trials within the previous two months
- •11. In the case of continuous consumption of food or processed food from raw material for experimental food within 2 weeks
- •12. Pregnant or lactating women
- •13. Subject who do not perform adequate contraception in women of childbearing age (except woman who undergo sterilization operation)
- •14. Subject who deemed inappropriate to participate this clinical trial by research director due to other reasons including screening test
研究者
相似试验
已完成
不适用
An 8-week, randomized, double-blinded, placebo-controlled clinical trial to evaluate the efficacy and safety of Lactobacillus plantarum HAC01 on the postprandial glucose levels.KCT0005652AtoGen40
招募中
不适用
A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccaharum Officinalis wax alcohols(Policosanol) on improvement of blood cholesterolKCT0006606Wonkwang University. Iksan Korean Medicine Hospital80
尚未招募
不适用
Clinical trial to evaluate the efficacy and safety of GyejigaChulbu-tang on degenerative osteoarthritisDiseases of the musculo-skeletal system and connective tissueKCT0003124Wonkwang University, Gwangju Medical Center56
已完成
不适用
Human trial study to evaluate the efficacy and safety of ISD on immune functioKCT0004387Medience80
已完成
不适用
A 8-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Beta-Glucan derived from Split gill Mushroom, Schizophyllum commune Fr. for improving intestinal healthKCT0006657Quegen Biotech80